Literature DB >> 1527538

Serum prolactin response to metoclopramide during status epilepticus.

U Lindbom1, T Tomson, B Y Nilsson, D E Andersson.   

Abstract

Transient elevation of serum prolactin frequently follows generalised tonic-clonic and complex partial seizures. However, the levels of prolactin during status epilepticus are not increased above the normal range. Exhaustion of central prolactin supplies has been proposed as a possible mechanism for the absence of prolactin increase during status epilepticus. To test this hypothesis we injected intravenous metoclopramide (10 mg) in eight consecutive patients with status epilepticus. One patient had generalised tonic-clonic status epilepticus. Seven patients had EEG-verified non-convulsive status epilepticus, consisting of one typical absence status, one atypical absence status and five complex partial status epilepticus. Metoclopramide raised the mean (SD) prolactin levels at least five-fold in all patients, from 5.8 (8.0) micrograms/l to 87.0 (39.0) micrograms/l, within 60 minutes after the injection. Thus the mechanism for low prolactin values in status epilepticus is not cellular depletion of stored prolactin, but more likely an altered regulation, presumably induced by prolonged seizure activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527538      PMCID: PMC489205          DOI: 10.1136/jnnp.55.8.685

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels.

Authors:  M L Rao; H Stefan; J Bauer
Journal:  Neuroendocrinology       Date:  1989-01       Impact factor: 4.914

2.  Serum prolactin evaluation after "minor" generalised seizures monitored by EEG.

Authors:  L Bilo; R Meo; S Striano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

3.  Serum prolactin in epilepsy and hysteria.

Authors:  M R Trimble
Journal:  Br Med J       Date:  1978-12-16

4.  Serum prolactin during status epilepticus.

Authors:  T Tomson; U Lindbom; B Y Nilsson; E Svanborg; D E Andersson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

5.  Pituitary responsiveness to gonadotrophin-releasing and thyrotrophin-releasing hormones in epileptic patients receiving carbamazepine or phenytoin.

Authors:  J Dana-Haeri; J Oxley; A Richens
Journal:  Clin Endocrinol (Oxf)       Date:  1984-02       Impact factor: 3.478

6.  Effects of carbamazepine on prolactin secretion in normal subjects and in epileptic subjects.

Authors:  U Bonuccelli; G Murialdo; E Martino; S Lecchini; M L Bonura; G Bambini; L Murri
Journal:  Clin Neuropharmacol       Date:  1985       Impact factor: 1.592

7.  Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patients.

Authors:  J I Isojärvi; V V Myllylä; A J Pakarinen
Journal:  Epilepsia       Date:  1989 Jan-Feb       Impact factor: 5.864

8.  Serum prolactin and cortisol levels in evaluation of pseudoepileptic seizures.

Authors:  P B Pritchard; B B Wannamaker; J Sagel; C M Daniel
Journal:  Ann Neurol       Date:  1985-07       Impact factor: 10.422

9.  Prolactin and gonadotrophin changes following generalised and partial seizures.

Authors:  J Dana-Haeri; M r Trimble; J Oxley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-04       Impact factor: 10.154

10.  Prolactin changes after seizures classified by EEG monitoring.

Authors:  K D Laxer; J P Mullooly; B Howell
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.